KELLI HANKS: Open Payments
NPI 1962041996 · LONGVIEW, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $534
Food & beverage: $454Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $277 |
| UCB, Inc. | 1 | $40 |
| Lilly USA, LLC | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| GENZYME CORPORATION | 1 | $31 |
| Paratek Pharmaceuticals, Inc. | 1 | $31 |
| Organon LLC | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: TREMFYA, DUPIXENT, Bimzelx, TALTZ, NUZYRA, COSENTYX, Rhapsido, SKYRIZI.
Industry payments across WA — which companies pay providers there.
